Kaya Holdings, Inc. (OTCQB:KAYS): The Sacred Mushroom, Oregon's Premier Psilocybin Treatment Center Introduces "Synergy by Design" Journey Customization Program
Kaya Holdings (OTCQB:KAYS) has announced the launch of 'Synergy by Design' at The Sacred Mushroom™ (TSM), their 11,000 sq. ft. psilocybin treatment center in Portland, Oregon. This new program allows participants to customize their psychedelic journey experience through personalized settings and activities.
The program enables guests to select their preferred environment, including space options (quiet nook, indoor garden, private room), customizable sound elements (live musicians, playlists, nature sounds), and aromatic preferences (essential oils, herbal infusions). Additionally, participants can engage in various activities such as creative expression through art, music, and crafting, as well as mind-body practices like yoga and meditation.
According to KAYS CEO Craig Frank, this initiative leverages the facility's extensive space to create an ideal psilocybin treatment setting, positioning The Sacred Mushroom™ as a pioneer in the $82.47 billion mental healthcare sector.
Kaya Holdings (OTCQB:KAYS) ha annunciato il lancio di 'Synergy by Design' presso The Sacred Mushroom™ (TSM), il loro centro di trattamento psilocibinico di 11.000 piedi quadrati a Portland, Oregon. Questo nuovo programma consente ai partecipanti di personalizzare la loro esperienza psichedelica attraverso impostazioni e attività personalizzate.
Il programma permette agli ospiti di selezionare l'ambiente preferito, comprese le opzioni di spazio (angolo tranquillo, giardino interno, stanza privata), elementi sonori personalizzabili (musicisti dal vivo, playlist, suoni della natura) e preferenze aromatiche (oli essenziali, infusioni di erbe). Inoltre, i partecipanti possono partecipare a varie attività, come l'espressione creativa attraverso l'arte, la musica e il crafting, oltre a pratiche mente-corpo come yoga e meditazione.
Secondo il CEO di KAYS, Craig Frank, questa iniziativa sfrutta l'ampio spazio della struttura per creare un ambiente ideale per il trattamento psilocibinico, posizionando The Sacred Mushroom™ come pioniere nel settore della salute mentale del valore di 82,47 miliardi di dollari.
Kaya Holdings (OTCQB:KAYS) ha anunciado el lanzamiento de 'Synergy by Design' en The Sacred Mushroom™ (TSM), su centro de tratamiento de psilocibina de 11,000 pies cuadrados en Portland, Oregón. Este nuevo programa permite a los participantes personalizar su experiencia de viaje psicodélico a través de configuraciones y actividades personalizadas.
El programa permite a los huéspedes seleccionar su entorno preferido, incluyendo opciones de espacio (rincones tranquilos, jardín interior, habitación privada), elementos sonoros personalizables (músicos en vivo, listas de reproducción, sonidos de la naturaleza) y preferencias aromáticas (aceites esenciales, infusiones de hierbas). Además, los participantes pueden participar en diversas actividades, como la expresión creativa a través del arte, la música y la artesanía, así como en prácticas de mente-cuerpo como yoga y meditación.
Según el CEO de KAYS, Craig Frank, esta iniciativa aprovecha el extenso espacio de la instalación para crear un entorno de tratamiento de psilocibina ideal, posicionando a The Sacred Mushroom™ como pionero en el sector de salud mental valorado en 82.47 mil millones de dólares.
Kaya Holdings (OTCQB:KAYS)는 포틀랜드 오레곤에 위치한 11,000 평방 피트 크기의 실로시빈 치료 센터인 The Sacred Mushroom™ (TSM)에서 'Synergy by Design'의 출범을 발표했습니다. 이 새로운 프로그램은 참가자들이 개인화된 설정과 활동을 통해 자신의 환각 여행 경험을 맞춤 설정할 수 있도록 합니다.
이 프로그램은 손님들이 자신의 선호 환경을 선택할 수 있게 하며, 공간 옵션(조용한 구석, 실내 정원, 개인실), 맞춤형 사운드 요소(라이브 뮤지션, 재생 목록, 자연의 소리), 그리고 아로마 선호(에센셜 오일, 허브 주입)를 포함합니다. 또한 참가자들은 예술, 음악, 공예를 통한 창의적인 표현 및 요가와 명상과 같은 마음-몸 실천에 참여할 수 있습니다.
KAYS의 CEO인 Craig Frank에 따르면, 이 이니셔티브는 시설의 넓은 공간을 활용하여 이상적인 실로시빈 치료 환경을 조성하고, The Sacred Mushroom™을 824억 7천만 달러 규모의 정신 건강 분야에서의 선구자로 자리매김하고 있습니다.
Kaya Holdings (OTCQB:KAYS) a annoncé le lancement de 'Synergy by Design' au The Sacred Mushroom™ (TSM), leur centre de traitement à la psilocybine de 11 000 pieds carrés à Portland, Oregon. Ce nouveau programme permet aux participants de personnaliser leur expérience de voyage psychédélique grâce à des paramètres et des activités personnalisés.
Le programme permet aux invités de choisir leur environnement préféré, y compris des options d’espace (coin tranquille, jardin intérieur, chambre privée), des éléments sonores personnalisables (musiciens live, playlists, sons de la nature) et des préférences aromatiques (huiles essentielles, infusions d’herbes). De plus, les participants peuvent s'engager dans diverses activités telles que l'expression créative à travers l'art, la musique et l'artisanat, ainsi que des pratiques corps-esprit comme le yoga et la méditation.
Selon Craig Frank, PDG de KAYS, cette initiative tire parti de l’espace vaste de l’établissement pour créer un cadre de traitement à la psilocybine idéal, positionnant The Sacred Mushroom™ comme un pionnier dans le secteur des soins de santé mentale d'une valeur de 82,47 milliards de dollars.
Kaya Holdings (OTCQB:KAYS) hat die Einführung von 'Synergy by Design' im The Sacred Mushroom™ (TSM), ihrem 11.000 Quadratfuß großen Psilocybin-Behandlungszentrum in Portland, Oregon, bekannt gegeben. Dieses neue Programm ermöglicht es den Teilnehmern, ihre psychedelische Reiseerfahrung durch personalisierte Einstellungen und Aktivitäten anzupassen.
Das Programm ermöglicht es den Gästen, ihre bevorzugte Umgebung auszuwählen, einschließlich Raumoptionen (ruhige Ecke, Innenhof, Privatzimmer), anpassbare Klangelemente (Live-Musiker, Wiedergabelisten, Naturgeräusche) und aromatische Präferenzen (ätherische Öle, Kräuterinfusionen). Darüber hinaus können die Teilnehmer an verschiedenen Aktivitäten teilnehmen, wie z.B. kreativem Ausdruck durch Kunst, Musik und Handwerken sowie Körper-Geist-Praktiken wie Yoga und Meditation.
Laut Craig Frank, dem CEO von KAYS, nutzt diese Initiative den umfangreichen Raum der Einrichtung, um eine ideale Psilocybin-Behandlungsumgebung zu schaffen, wodurch The Sacred Mushroom™ als Pionier im 82,47 Milliarden Dollar schweren Sektor der psychischen Gesundheitsversorgung positioniert wird.
- Launch of innovative customizable treatment program 'Synergy by Design'
- Large-scale 11,000 sq. ft. facility offering comprehensive treatment options
- Operating in the $82.47 billion mental healthcare sector
- Legal authorization from Oregon State for psilocybin treatments
- None.
PORTLAND, OR / ACCESS Newswire / January 16, 2025 / Kaya Holdings, Inc. (OTCQB:KAYS) and The Sacred Mushroom™ ("TSM"), Portland's one-of-a-kind psilocybin treatment center today announced the launch of "Synergy by Design," a revolutionary program that empowers individuals to curate deeply personal and transformative psychedelic journeys. By combining intention, sensory customization, and meaningful activities, this program is designed to ensure that every participant's experience reflects their unique needs, preferences, and goals.
The Sacred Mushroom™, at 11,000 sq. ft., has been purposely curated to provide every TSM guest with the full transformative potential of the psychedelic journey. Guests can access their perfect setting through TSM's proprietary "Synergy by Design" and interact with journey-enhancing activities such as art expression, body movement, and journaling.
What is Synergy by Design?
Synergy by Design is a framework rooted in personalization and empowerment, offering participants the tools to craft their own transformative psilocybin journeys. Each step invites individuals to align their surroundings, activities, and intentions to create meaningful experiences.
With Synergy by Design, The Sacred Mushroom™ guest can select their surroundings, creating a sensory environment that aligns with their goals by customizing:
Space: Guests choose from serene settings like a quiet nook, lush indoor garden, or private room for maximum comfort and inspiration.
Sounds: Music or ambient sounds, with options including live musicians, curated playlists, or nature's calming white noise.
Scents: Essential oils, herbal infusions, or natural room fragrances to complete the sensory palette.
Synergy By Design further provides activities for guests to tailor to enhance their experience:
Creative Expression: Painting, journaling, crafting, clay sculpturing, kinetic sand, and musical instruments provided.
Mind-Body Connection: An area reserved for yoga, meditation, or body movement exercises.
"At The Sacred Mushroom™, we believe every individual deserves a journey that reflects their unique spirit and aspirations," said Bryan Arnold, Chief Facilitator at The Sacred Mushroom™. Synergy by Design's objective is to ensure that every detail is curated to support our guest."
KAYS CEO Statement
"This unique program is possible because of the size of our facility and our commitment to transform the space into the absolutely ideal psilocybin treatment setting," stated KAYS' CEO Craig Frank. "Synergy By Design is the next step toward achieving the experience we seek to provide, enabling the guest to construct their own visual, auditory and olfactory inputs. It is the ultimate in crafting a personal psilocybin journey. This program is yet another example of how The Sacred Mushroom™ is pioneering psychedelics and setting the stage for change in the
About The Sacred Mushroom™ (https://thesacredmushroompdx.com)
The Sacred Mushroom™ is a legally licensed psilocybin treatment center authorized by the State of Oregon to administer psilocybin treatments within the regulations set forth by the Oregon Health Authority.
For more information or to make an appointment for psilocybin services at The Sacred Mushroom™, please go to https://tsmpdx.com or send an email to info@tsmpdx.com
About Kaya Holdings, Inc. (https://kayaholdings.com)
Kaya Holdings, Inc is a "mind care" company with operations in the emerging psilocybin sector and in medical/recreational cannabis. KAYS is a fully reporting, US-based publicly traded company, listed for trading on the OTCQB market under the symbol KAYS.
In 2014 KAYS became the first US public company to own and operate a medical cannabis dispensary (in Portland, Oregon). Today, KAYS has interests in three cannabis licenses (1 in Portland Oregon, USA and 2 in Greece). Resuming its role as innovator and trend setter, the Company is again breaking ground in the United States with The Sacred Mushroom™ psychedelic treatment centers through its majority owned subsidiary, Fifth Dimension Therapeutics, Inc. ("FDT").
KAYS Stockholders and Other Interested Parties - Please Update Your Contact Information:
We routinely receive calls and emails from stockholders and other interested parties seeking an update on our operations. We are asking all KAYS stockholders and interested parties to email us and confirm their contact info. Please email info@kayaholdings.com with "KAYS stockholder update" in the subject line and include your name, address, phone number and number of shares you own so that we can make sure you receive all updates and respond to inquiries. If you would like to speak to someone at the Company, please call or text 954-480-3960 and someone will promptly get back to you.
Important Disclosure
KAYS is planning execution of its stated business objectives in accordance with current understanding of state and local laws and federal enforcement policies and priorities as it relates to psychedelics and cannabis. Potential investors and shareholders are cautioned that KAYS and subsidiaries including FDT will obtain advice of counsel prior to actualizing any portion of their business plan (including but not limited to license applications for the cultivation, distribution or sale of marijuana and psychedelic products, engaging in said activities or acquiring existing production/sales operations). Advice of counsel with regard to specific activities of KAYS, federal, state, or local legal action or changes in federal government policy and/or state and local laws may adversely affect business operations and shareholder value.
Forward-Looking Statements
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Contact:
W. David Jones
954-480-3960
SOURCE: Kaya Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
What is the Synergy by Design program launched by KAYS at The Sacred Mushroom?
How large is KAYS' The Sacred Mushroom facility in Portland?
What customization options does KAYS offer in the Synergy by Design program?
What is the market size of the mental healthcare sector that KAYS is targeting?
